Review of Diabetes Drug Saxagliptin Extended
Links shared publicly online about this topic
Kombiglyze XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 Diabetes Mellitus in Adults
drugs.com — “Kombiglyze XR (saxagliptin and metformin) is used to treat type 2 diabetes. Includes Kombiglyze XR side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 7, 2010 at 10:13 pm By:
Drugs and Devices OW OW Health
Kombiglyze XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatm... http://bit.ly/blx4wx #drug
Kombiglyze XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 Diabetes Mellitus in Adults
drugs.com — “Kombiglyze XR (saxagliptin and metformin) is used to treat type 2 diabetes. Includes Kombiglyze XR side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 7, 2010 at 9:55 pm By:
FDA Approves Kombiglyze XR (saxagliptin and metformin) for the Treatment of Type 2 Diabetes Mellitus - http://bit.ly/bGBTlz
Kombiglyze™ Xr (Saxagliptin And Metformin Hcl Extended-Release) Tablets Approved In The U.S. For The Treatment Of Type 2 Diabetes Mellitus In Ad
medicalnewstoday.com — “Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) approved KOMBIGLYZE™ XR for the treatment of type 2 diabetes i” View full resource at medicalnewstoday.com
Most Recently Shared on November 8, 2010 at 6:05 pm By:
Kombiglyze™ Xr (Saxagliptin And Metformin Hcl Extended-Release) Tablets Approved In The U.S. For The Treatment O... http://mnt.to/3Mcv
KOMBIGLYZE XR (Saxagliptin and Metformin HCl Extended-Release) Tablets, a New Treatment for Type 2 Diabetes Mellitus in Adults, Now Available in U.S. Pharmacies - Drugs.com MedNews
drugs.com — “The first and only once-a-day metformin extended-release (XR) plus DPP-4 inhibitor combination tablet Jan 7, 2011 - Bristol-Myers Squibb Company (NYSE BMY), and” View full resource at drugs.com
Most Recently Shared on January 8, 2011 at 6:07 am By:
Drugs and Devices OW OW Health
KOMBIGLYZE XR (Saxagliptin and Metformin HCl Extended-Release) Tablets, a New Treatment for Type 2 Diabete... http://bit.ly/epdTOV #drug
KOMBIGLYZE" XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 Diabetes Mellitus in Adults
businesswire.com — “Bristol-Myers Squibb and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved KOMBIGLYZE™ XR for the treatment” View full resource at businesswire.com
Most Recently Shared on November 6, 2010 at 5:28 pm By:
KOMBIGLYZEâ„¢ XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. (BioSpace) http://bit.ly/c9ijsw
Exenatide Once Weekly New Drug Application Review Extended By FDA Due To Weather-Related Closure
medicalnewstoday.com — “Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) confirmed that the U.S. Food and Drug Administration (FDA) has set a new Prescripti” View full resource at medicalnewstoday.com
Most Recently Shared on February 28, 2010 at 1:05 pm By:
Exenatide Once Weekly New Drug Application Review Extended By FDA Due To Weather-Related Closure http://mnt.to/3ydH #diabetes
Exenatide Once Weekly New Drug Application Review Extended By FDA Due To Weather-Related Closure | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Exenatide Once Weekly New Drug Application Review Extended By FDA Due To Weather-Related Closure | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on March 1, 2010 at 6:15 pm By:
Exenatide Once Weekly New Drug Application Review Extended By FDA Due To Weather-Related Closure http://tinyurl.com/yfzh4ou - Keyvive
Merck Announces FDA Acceptance Of New Drug Application For An Investigational Extended-Release Formulation Of JANUMET(R) For Type 2 Diabetes
medicalnewstoday.com — “Merck announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S.” View full resource at medicalnewstoday.com
Most Recently Shared on January 13, 2011 at 3:05 pm By:
Merck Announces FDA Acceptance Of New Drug Application For An Investigational Extended-Release Formulation Of JANUMET(... http://mnt.to/3PWH
FDA accepts NDA for extended-release Janumet for type 2 diabetes - MPR
empr.com — “Merck announced that the New Drug Application (NDA) for its investigational extended-release formulation of Janumet (sitagliptin/metformin HCI) for type 2 diabetes has been accepted for standard review by the FDA.” View full resource at empr.com
Most Recently Shared on January 13, 2011 at 3:38 pm By:
MPR News: FDA accepts NDA for extended-release Janumet for type 2 diabetes: Merck announced that the New Drug Ap... http://bit.ly/hVcolP
Kombiglyze XR tablets approved for the treatment of type 2 diabetes mellitus in adults - - Drug Topics
drugtopics.modernmedicine.com — “FDA has approved saxagliptin and metformin extended-release (XR) (Kombiglyze XR, AstraZeneca/Bristol-Myers Squibb) tablets for the treatment of type 2 diabetes in adults. Kombiglyze XR is the first and only once-a-day metformin XR plus dipeptidyl peptidase-4 (DPP-4) inhibitor combination tablet offering strong glycemic control across glycosylated hemoglobin levels, fasting plasma glucose, and postprandial glucose.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on November 12, 2010 at 2:02 pm By:
Kombiglyze XR tablets approved for the treatment of type 2 diabetes mellitus in adults: FDA has approved saxagli... http://bit.ly/cIZrir
FDA approved KOMBIGLYZE XR for type 2 diabetes mellitus now available in pharmacies
news-medical.net — “Bristol-Myers Squibb Company, and AstraZeneca today announced that KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release), approved by the U.S. Food and Drug Administration (FDA) on November 5, 2010, is now available by prescription in pharmacies across the United States.” View full resource at news-medical.net
Most Recently Shared on January 7, 2011 at 5:01 pm By:
FDA approved KOMBIGLYZE XR for type 2 diabetes mellitus now available in pharmacies: Bristol-Myers Squibb Compan... http://bit.ly/dLge7K
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on January 11, 2011 at 2:39 pm By:
eyeonfda Pharma and Health Lawyer
Merck Gets FDA Acceptance of NDA for Investigational Extended-Release Formulation of JANUMET® #Diabetes http://ow.ly/3BOiG
As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution - Drugs.com MedNews
drugs.com — “When the U.S. Food and Drug Administration announced Monday it was investigating possible links between widely used hormonal prostate cancer drugs and an slight” View full resource at drugs.com
Most Recently Shared on May 4, 2010 at 11:24 pm By:
As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution - http://bit.ly/aM38UT
As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution:
health.msn.com — “As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution:” View full resource at health.msn.com
Most Recently Shared on May 4, 2010 at 7:55 pm By:
As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution: http://bit.ly/9dDywc
Bristol-Myers Squibb: Press Releases
bms.com — “Bristol-Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines that help patients prevail over serious diseases.” View full resource at bms.com
Most Recently Shared on April 23, 2009 at 1:23 pm By:
eyeonfda Pharma and Health Lawyer
U.S. Food and Drug Administration Extends Review Timeline for ONGLYZAâ„¢ (saxagliptin) New Drug Application - http://twurl.nl/58vea3
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
MNT Diabetes News
The latest diabetes news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
